| Xiao Hui Guan |
Xiao Hui Guan currently works at Sinopharm Group Co., Ltd., as Chairman-Supervisory Board, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., as Co-Chairman from 2025, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., as Director, Shanghai Fosun Long March Medical Science Co., Ltd., as Director, Yaneng BIOscience (Shenzhen) Co., Ltd., as Director, Fosun Pharma Industrial Pte Ltd., as Executive Director from 2021, Shanghai Henlius Biotech, Inc., as Non-Executive Director from 2018, Shanghai Foshion Medical System Co., Ltd., as Director, Association of Chartered Certified Accountants, as Member, Fosun International Ltd., as Vice President, Shanghai Fosun Pingyao Investment & Management Co., Ltd., as Member-Supervisory Board, Sinopharm Industrial Investment Co., Ltd., as Member-Supervisory Board, Shanghai Fosun Health Technology (Group) Co., Ltd., as Member-Supervisory Board, and Fochon Pharmaceuticals Ltd., as Member-Supervisory Board. Ms. Guan also formerly worked at Saladax Biomedical, Inc., as Director, Gland Pharma Ltd., as Non-Executive Director from 2019 to 2022, Biosino Bio-Technology & Science, Inc., as Member-Supervisory Board from 2011 to 2015, China National Accord Medicines Corp. Ltd., as Member-Supervisory Board, and Shanghai Fosun Pharmaceutical Co. Ltd., as Controller. Ms. Guan received her graduate degree in 2007 from The Chinese University of Hong Kong and undergraduate degree from Jiangxi University of Finance & Economics. |
| Xiu Chang Jiang |
Mr. Xiu Chang Jiang is a Chairman at Sinopharm Holdings Inner Mongolia Co., Ltd., a Chairman at Sinopharm Holding Shanxi Co., Ltd., a Vice President at Sinopharm Group Co., Ltd., a Chairman at Sinopharm Holdings Jiangxi Co. Ltd., a Chairman at Sinopharm Holdings Tianjin Co. Ltd. and a Chairman at Sinopharm Medicine Holding Shanxi Co., Ltd. He is on the Board of Directors at China National Finance Co. Ltd., Sinopharm Group Finance Co. Ltd., Sinopharm Holding Hong Kong Co., Ltd., Sinopharm Le Ren Tang Co., Ltd., Sinopharm Holding Distribution Co. Ltd., China National Shanxi Co. Ltd., Yujia Medical Service Co. Ltd., Sinopharm Guoda Pharmacy and Sinopharm Lerentang Pharmaceutical Co., Ltd. Mr. Jiang was previously employed as a Member-Supervisory Board by Sinopharm Holding Beijing Co., Ltd., a Member-Supervisory Board by Sinopharm Holding GuoDa Drug Store Co., Ltd., and a Chairman by China National Medicines Co., Ltd. He also served on the board at China National Accord Medicines Corp. Ltd. He received his undergraduate degree from Zhongnan University of Economics & Law and a graduate degree from the University of International Business & Economics. |
| Bing Xiang Zhao |
Bing Xiang Zhao currently works at Sinopharm Group Co., Ltd., as Chairman from 2024 and China National Pharmaceutical Group Co., Ltd., as General Manager & Director. Dr. Zhao received his doctorate degree from Zhejiang University, undergraduate degree from Shenyang Pharmaceutical University, and graduate degree from Peking University School of Pharmaceutical Sciences. |
| Wan Yong Lian |
Wan Yong Lian's current job(s) include being the President & Executive Director at Sinopharm Group Co., Ltd. since 2024, and being a Director at Xinjiang Co. since 2009. He is also a Member-Supervisory Board at Sinopharm Holding Guoda Drugstores Co., Ltd. and Sinopharm Holding GuoDa Drug Store Co., Ltd.Mr. Lian's former job(s) include being the President & Director at Shanghai Shyndec Pharmaceutical Co., Ltd. from 2022 to 2024. He was also a Member-Supervisory Board at Sinopharm Group Co., Ltd. from 2008 to 2018. Additionally, he held a position in the Investment Management Department at China National Pharmaceutical Group Co., Ltd. and was the Manager of the Operation & Audit Department at Traditional & Herbal Medicine Co. from 2004 to 2005. Mr. Lian's education history includes an MBA from the University of Miami in 2002. He also completed his undergraduate degree at Central South University in 1993 and a graduate degree at Sun Yat-Sen University in 1996. |
